Male overactive bladder treatment: new possibilities and perspectives
Keywords:cholinoblockers, overactive bladder, lower urinary tract symptoms
AbstractAnalysis of modern data about possibilities and perspectives of cholinoblockers (CB) usage for male overactive bladder treatment was performed. The data proved effectiveness and safety of lower urinary tract symptoms/benign prostatic hyperplasia with CB treatment. Nevertheless CB don’t used for treatment of male with another dysuric conditions and qualitative studies in this problem are absent. So great perspectives are exist for CB treatment of male with another pathology.
Abrams P., Cardoso L., Fall M. et al. The standardization of terminology of low urinary tract function: report from the standardization sub_committee of the ICS // Urology. – 2003. – 61. – Р. 37–49.
Bissada N.K., Finkbeiner A.E. Lower urinary tract function and dysfunction. – N.-Y.: ACC, 1978. – 276 p.
Irwin D., Milson I., Reilly K. et al. Prevalence of overactive bladder syndrome: European results from the EPIC study// Eur. Urol. Suppl. – 2006. – Vol. 5, No 2. – P. 115.
Пирогов В.О., Зайцев В.І., Сівбистянова Н.А., Андреєва І.А. Нейрогенний сечовий міхур. Частина 2. Загальні принципи діагностики та лікування// Урологія. – 1997. – No 3. – С. 74–81.
Harvey MA, Baker K, Wells GA. Tolterodine versus oxybutynin in the treatment of urge urinary incontinence: a meta_analysis // Am J. Obstet Gynecol. – 2001. – Vol. 185. – Р. 56–61.
Chapple C.R., Rechberger T., Al-Shukri S. et al. Randomized, double-blind placebo and tolterodine_controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder // BJU International, – 2004. – Vol. 93. – Р. 303–310.
Chapple C., Fiala R., Gorilovsky L., Pasechnikov S. et al. The STAR study: analysis of symptom severity and treatment response in overactive bladder // Eur. Urol. Suppl. – 2006. – Vol. 5 (2).– Р. 117.
Chancellor M, Zinner N, Whitmore K et al. Efficacy of Solifenacin in patient previously treated with tolterodine extended release 4 mg: result of 12 – week, multicenter, open-label, flexible-dose study. Clin Ther 2008; 30: 1766–81.
Garely AD, Kaufman JM, Sand PK et al. Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the Vesicare Open Label Trial (VOLT). Clin Ther 2006; 28: 1935–46.
Samuels TA, Mitcheson HD, Vardy MD et al. Solifenacin significantly improves overactive bladder symptoms, symptom-associated bother and other patient-related outcomes: Results from VIBRANT, a double-blind, placebo-controlled trial. EAU annual meeting, 2009; (Abstr. 190).
Drake MJ, et al. Long-term Safety and Efficacy of Single-tablet Combinations of Solifenacin and Tamsulosin Oral Controlled Absorption System in Men with Storage and Voiding Lower Urinary Tract Symptoms: Results from the NEPTUNE Study and NEPTUNE II Open-label Extension. Eur Urol (2014), http://dx.doi.org/10.1016/j.eururo.2014.07.013.
Copyright (c) 2020 В. І. Зайцев
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The journal does not require authors of original (primary) research papers to assign the copyright of their published contributions. Authors grant the journal an non-exclusive licence CC BY 4.0 (Creative Commons Attribution 4.0 International License) to using and the first publication of the original in this journal. Copyright of the manuscripts is retained by the authors, after publication authors retain rights to reuse their papers in their future printed work without first requiring permission from the publisher of the journal and share their own published articles.
The journal supports the self-archiving process. Prior to publication in the journal, authors may post a copy of their manuscript in preparation or submitted to the journal in recognized non-commercial preprint servers, public websites. Authors also are encouraged to archive their final author version of the manuscript in their institution's repositories and, if they wish, on their personal websites. Authors should cite the publication reference and DOI number on the first page of any deposited version, and provide a link from it to the URL of the published article on the journal's website.
To facilitate self-archiving of original research papers and help authors fulfil funder and institutional mandates, the journal deposits manuscripts in National Library of Ukraine by V.I. Vernadsky, Scientific periodicals of Ukraine database and different international scintificd database on behalf of authors who opt-in to this free service during submission. The journal provides depositing of articles on official website of the publisher. The full text access to published papers is free.